Jorma J Palvimo (Ville Paakinaho)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 25

Top Topics

Transcription Factor

Radical Prostatectomy

Long Noncoding Rna

Top Venues

Nucleic acids research

Communications biology

Cellular and molecular life sciences : CMLS

This page only lists publications with an associated author ORCID identifier.

Publications

Céline Van Dender, Steven Timmermans, Jorma J Palvimo, Tineke Vanderhaeghen, Jolien Vandewalle, Maarten Claes, Bruno Garcia, Bart Roman, Jan J De Waele, Siska Croubels, Karolien De Bosscher, Philip Meuleman, Antoine Herpain, Jorma J Palvimo, Claude Libert
A critical role for HNF4α in polymicrobial sepsis-associated metabolic reprogramming and death. EMBO molecular medicine (2024)
Kaisa-Mari Launonen, Vera Varis, Niina Aaltonen, Einari A Niskanen, Markku Varjosalo, Jorma J Palvimo, Jorma J Palvimo
Central role of SUMOylation in the regulation of chromatin interactions and transcriptional outputs of the androgen receptor in prostate cancer cells. Nucleic acids research (2024)
Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi, Ladan Fazli, Sonia H Y Kung, Jaana M Hartikainen, Jorma J Palvimo, Janne Capra, Kirsi Rilla, Marjo Malinen, Petri I Mäkinen, Suo Ctc Bladder Committee, Amina Zoubeidi, Yuzhuo Z Wang, Martin E Gleave, Mikko Hiltunen, Kirsi Ketola
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. Communications biology 7 (1) (2024)
Noora Leppänen, Heidi Kaljunen, Eerika Takala, Roosa Kaarijärvi, Petri I Mäkinen, Suo Ctc Bladder Committee, Ilkka Paatero, Jorma J Palvimo, Kirsi Ketola
SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer. Nucleic acids research 52 (10) (2024)
Jasmin Huttunen, Niina Aaltonen, Laura Helminen, Kirsi Rilla, Jorma J Palvimo
EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi, Ladan Fazli, Sonia H Y Kung, Jaana M Hartikainen, Jorma J Palvimo, Janne Capra, Kirsi Rilla, Marjo Malinen, Petri I Mäkinen, Suo Ctc Bladder Committee, Amina Zoubeidi, Yuzhuo Z Wang, Martin E Gleave, Mikko Hiltunen, Kirsi Ketola
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. Communications biology 7 (1) (2024)
Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi, Ladan Fazli, Sonia H Y Kung, Jaana M Hartikainen, Jorma J Palvimo, Janne Capra, Kirsi Rilla, Marjo Malinen, Petri I Mäkinen, Suo Ctc Bladder Committee, Amina Zoubeidi, Yuzhuo Z Wang, Martin E Gleave, Mikko Hiltunen, Kirsi Ketola
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. Communications biology 7 (1) (2024)
Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi, Ladan Fazli, Sonia H Y Kung, Jaana M Hartikainen, Jorma J Palvimo, Janne Capra, Kirsi Rilla, Marjo Malinen, Petri I Mäkinen, Suo Ctc Bladder Committee, Amina Zoubeidi, Yuzhuo Z Wang, Martin E Gleave, Mikko Hiltunen, Kirsi Ketola
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. Communications biology 7 (1) (2024)
Kirsi Kainulainen, Einari A Niskanen, Johanna Kinnunen, Kaisa Mäki-Mantila, Kiia Hartikainen, Jorma J Palvimo, Marjo Malinen, Kirsi Ketola, Sanna Pasonen-Seppänen
Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2 , and CD44 through NFκB-signaling. Oncoimmunology 13 (1) (2024)
Jasmin Huttunen, Niina Aaltonen, Laura Helminen, Kirsi Rilla, Jorma J Palvimo
EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Kirsi Kainulainen, Einari A Niskanen, Johanna Kinnunen, Kaisa Mäki-Mantila, Kiia Hartikainen, Jorma J Palvimo, Marjo Malinen, Kirsi Ketola, Sanna Pasonen-Seppänen
Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2 , and CD44 through NFκB-signaling. Oncoimmunology 13 (1) (2024)
Noora Leppänen, Heidi Kaljunen, Eerika Takala, Roosa Kaarijärvi, Petri I Mäkinen, Suo Ctc Bladder Committee, Ilkka Paatero, Jorma J Palvimo, Kirsi Ketola
SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer. Nucleic acids research (2024)
Jasmin Huttunen, Niina Aaltonen, Laura Helminen, Kirsi Rilla, Jorma J Palvimo
EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Jasmin Huttunen, Niina Aaltonen, Laura Helminen, Kirsi Rilla, Jorma J Palvimo
EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Noora Leppänen, Heidi Kaljunen, Eerika Takala, Roosa Kaarijärvi, Petri I Mäkinen, Suo Ctc Bladder Committee, Ilkka Paatero, Jorma J Palvimo, Kirsi Ketola
SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer. Nucleic acids research 52 (10) (2024)
Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi, Ladan Fazli, Sonia H Y Kung, Jaana M Hartikainen, Jorma J Palvimo, Janne Capra, Kirsi Rilla, Marjo Malinen, Petri I Mäkinen, Suo Ctc Bladder Committee, Amina Zoubeidi, Yuzhuo Z Wang, Martin E Gleave, Mikko Hiltunen, Kirsi Ketola
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. Communications biology 7 (1) (2024)
Roosa Kaarijärvi, Heidi Kaljunen, Lucia Nappi, Ladan Fazli, Sonia H Y Kung, Jaana M Hartikainen, Jorma J Palvimo, Janne Capra, Kirsi Rilla, Marjo Malinen, Petri I Mäkinen, Suo Ctc Bladder Committee, Amina Zoubeidi, Yuzhuo Z Wang, Martin E Gleave, Mikko Hiltunen, Kirsi Ketola
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. Communications biology 7 (1) (2024)
Noora Leppänen, Heidi Kaljunen, Eerika Takala, Roosa Kaarijärvi, Petri I Mäkinen, Suo Ctc Bladder Committee, Ilkka Paatero, Jorma J Palvimo, Kirsi Ketola
SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer. Nucleic acids research 52 (10) (2024)
Laura Helminen, Jasmin Huttunen, Melina Tulonen, Niina Aaltonen, Einari A Niskanen, Jorma J Palvimo, Jorma J Palvimo
Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer. Nucleic acids research (2023)
Kaustubh Wagh, Diana A Stavreva, Rikke A M Jensen, Jorma J Palvimo, Gregory Fettweis, R Louis Schiltz, Daniel Wüstner, Susanne Mandrup, Diego Martín Presman, Arpita Upadhyaya, Gordon L Hager
Dynamic switching of transcriptional regulators between two distinct low-mobility chromatin states. Science advances 9 (24) (2023)
Ville Paakinaho, Jorma J Palvimo
Genome-wide crosstalk between steroid receptors in breast and prostate cancers. Endocrine-related cancer 28 (9) (2021)
David A Garcia, Gregory Fettweis, Diego M Presman, Jorma J Palvimo, Christopher Jarzynski, Arpita Upadhyaya, Gordon L Hager
Power-law behavior of transcription factor dynamics at the single-molecule level implies a continuum affinity model. Nucleic acids research 49 (12) (2021)
Thomas A Johnson, Jorma J Palvimo, Sohyoung Kim, Gordon L Hager, Diego Martín Presman
Genome-wide binding potential and regulatory activity of the glucocorticoid receptor's monomeric and dimeric forms. Nature communications 12 (1) (2021)
Kaisa-Mari Launonen, Jorma J Palvimo, Gianluca Sigismondo, Marjo Malinen, Reijo Sironen, Jaana M Hartikainen, Hanna Laakso, Tapio Visakorpi, Jeroen Krijgsveld, Einari A Niskanen, Jorma J Palvimo
Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells. Oncogene 40 (27) (2021)
Tineke Vanderhaeghen, Steven Timmermans, Deepika Watts, Jorma J Palvimo, Melanie Eggermont, Jolien Vandewalle, Charlotte Wallaeys, Lise Van Wyngene, Kelly Van Looveren, Louise Nuyttens, Sylviane Dewaele, Joke Vanden Berghe, Kelly Lemeire, Joey De Backer, Laura Dirkx, Wim Vanden Berghe, Guy Caljon, Bart Ghesquière, Karolien De Bosscher, Ben Wielockx, Jorma J Palvimo, Rudi Beyaert, Claude Libert
Reprogramming of glucocorticoid receptor function by hypoxia. EMBO reports (2021)